Dexcom Stelo Review: Features & Performance for Non-Diabetics

Introduction to Dexcom Stelo

The Dexcom Stelo represents a significant shift in continuous glucose monitoring technology. As Dexcom's first over-the-counter CGM, the Stelo opens access to glucose tracking for a population that previously had limited options: adults with type 2 diabetes who don't use insulin, those with prediabetes, and anyone curious about how daily choices—meals, sleep patterns, stress—affect their glucose levels.

Unlike prescription CGMs designed for intensive diabetes management, the Stelo is built for metabolic awareness rather than medical dosing decisions. It's approved for adults 18 and older who want glucose data without the barriers of a doctor's visit or insurance pre-authorization. For many readers navigating a new prediabetes diagnosis or managing type 2 diabetes with lifestyle and oral medications, the Stelo offers a window into patterns that blood-glucose meters can't capture: overnight trends, post-meal peaks, and the glucose impact of a skipped lunch or a stressful afternoon.

This review examines what the Stelo delivers in practice—its core features, accuracy in everyday use, what the app shows (and what it leaves out), and whether the monthly cost aligns with the insights it provides. If you're weighing over-the-counter CGM options, this breakdown clarifies where the Stelo fits and who benefits most from its design.

What the Stelo Is—and Isn't

The Stelo is a wearable sensor that tracks glucose every few minutes and sends the data to a smartphone app. Each sensor lasts up to 15 days, and the system requires no fingerstick calibration. It's designed for trend-watching, not for making medication or insulin decisions. The app provides glucose readings, daily summaries, and pattern insights, but it does not offer the customizable high/low alarms found in prescription CGMs.

For readers newly diagnosed with prediabetes or type 2 diabetes, the Stelo can clarify what "watch your carbs" actually means in your own body. For caregivers coordinating a household member's diabetes care, it can surface patterns—like consistent morning highs or post-dinner spikes—that inform the next doctor's appointment. It is not a diagnostic tool, and it does not replace regular A1C testing or clinical glucose monitoring when those are indicated.

The sections that follow detail the Stelo's feature set, user experiences from real-world wear, pricing structure, and a final assessment of where it delivers value and where it falls short.

Key Features of the Stelo CGM

The Dexcom Stelo stands out as the first over-the-counter continuous glucose monitor (CGM) to receive FDA clearance, meaning you can purchase it without a prescription or insurance approval. This marks a significant shift in glucose monitoring accessibility for people who don't use insulin — those with prediabetes, type 2 diabetes managed without insulin, or anyone curious about how food and activity affect their glucose patterns.

Real-Time Glucose Tracking Without Finger Pricks

Stelo delivers 288 glucose readings per day — one every five minutes, around the clock. Each sensor can be worn for up to 15 days before replacement, with no finger pricks or manual scans required. The system transmits data directly to your smartphone, giving you a continuous view of glucose trends rather than isolated snapshots.

This frequency matters when you're trying to connect a meal or a workout to what happens next. A single finger-stick reading tells you where you are at one moment; a continuous trace shows you the slope — whether glucose is climbing, plateauing, or dropping — and how quickly.

Accuracy and Performance Metrics

Dexcom reports the Stelo's accuracy as a Mean Absolute Relative Difference (MARD) of 9.8 percent. MARD is the standard measure of how closely a CGM's readings match lab reference values — lower numbers mean tighter agreement. A MARD below 10 percent is considered solid performance for non-insulin users, where the clinical stakes of a reading being off by a few points are lower than they would be for someone dosing rapid-acting insulin.

For context: if your actual glucose is 100 mg/dL, a 9.8 percent MARD means the sensor reading could be roughly 90–110 mg/dL on average. That's precise enough to see patterns — the post-meal spike, the overnight dip — even if individual readings aren't lab-grade.

Who the Stelo Is Designed For

The Stelo is cleared for adults 18 and older who do not use insulin. It's not approved for people with type 1 diabetes, anyone on insulin therapy, or those who need readings to make immediate treatment decisions (like correcting hypoglycemia). If you're managing diabetes with insulin, you'll need a prescription CGM like the Dexcom G7, which has tighter accuracy specs and low-glucose alerts.

For those exploring best CGM options for non-diabetics, the Stelo offers a straightforward entry point — no prior authorization, no insurance paperwork, and a form factor that's familiar if you've seen other Dexcom sensors.

The Stelo translates 15 days of continuous data into a readable story about your glucose behavior — no guesswork, no finger pricks.

User Experiences with the Stelo CGM

Real-world use of the Dexcom Stelo reveals how continuous glucose monitoring translates into everyday decisions — and where the device's design meets the messy reality of travel, meals, and behavior change. Users report both meaningful insights and practical friction points that shape whether the Stelo becomes a long-term tool or a short experiment.

What Users Appreciate

The Stelo's core strength lies in making invisible metabolic patterns visible. One user discovered during a 17-hour flight that prolonged sitting spiked glucose levels in ways that walking after meals counteracted — a pattern they would never have noticed without real-time feedback. Another found that a 10-minute post-dinner walk reduced their average glucose spike from 148 to 124 mg/dL, turning abstract advice about movement into concrete, personalized data.

Integration with other wearables adds depth for users already tracking sleep or stress. Pairing the Stelo with devices like the Oura Ring allows correlation between glucose variability and sleep quality or stress markers — useful context for anyone trying to untangle why certain days feel harder metabolically. For readers comparing options, our guide to the best CGM for non diabetics covers how different systems handle cross-device data sharing.

Common Concerns and Limitations

The Stelo's 15-day sensor life and lack of real-time alerts create practical constraints. Users managing prediabetes or metabolic curiosity appreciate the trend data but note that the system doesn't warn of rapid glucose changes — a design choice that suits its over-the-counter audience but limits utility for anyone needing immediate feedback. The app's focus on patterns over alarms means users must check in actively rather than relying on the device to interrupt their day.

Sensor adhesion during exercise or humid conditions varies by user, and the two-week replacement cycle adds recurring cost that some find harder to justify once the novelty of initial data collection fades. The lack of insurance coverage for non-diabetic use means the full cost lands on the user, which can shift the value calculation depending on how actionable the insights prove over time.

Pricing and Availability of the Dexcom Stelo

The Dexcom Stelo is available over-the-counter without a prescription, which removes a significant barrier for people with prediabetes or type 2 diabetes who don't use insulin. The OTC pathway means you can purchase the system directly from Dexcom's website or from select retail partners without needing a doctor's order or prior authorization from an insurance company.

Cost Structure

Stelo is sold on a subscription basis. Each sensor lasts 15 days, and the standard subscription delivers two sensors per month (30 days of coverage). Pricing is structured to encourage ongoing use rather than one-time purchases, which aligns with Dexcom's goal of building long-term engagement with glucose monitoring.

Because Stelo is an OTC device, it is not typically covered by health insurance or Medicare. You pay out-of-pocket, and the monthly cost is comparable to other consumer wellness subscriptions. For readers exploring OTC continuous glucose monitors more broadly, our guide to the best CGM for non diabetics compares pricing and features across several systems.

Where to Buy

Stelo is available directly from Dexcom's website, where you can set up a subscription and manage shipments. The company has also announced partnerships with select pharmacy and retail chains, though availability may vary by location. Check Dexcom's site for the current list of retail partners.

Who Qualifies

Stelo is FDA-cleared for adults (18 and older) who do not use insulin. This includes people with type 2 diabetes managed with oral medications or lifestyle changes, people with prediabetes, and people without diabetes who want to monitor their glucose patterns. It is not cleared for people who take insulin, children, or pregnant individuals.

Payment Options

Dexcom offers flexible subscription options, including the ability to pause or cancel your plan. Payment is typically processed monthly, and you can update your billing details through your online account. Some users may be able to use a Health Savings Account (HSA) or Flexible Spending Account (FSA) to pay for Stelo, though you should confirm eligibility with your plan administrator.

Conclusion on the Dexcom Stelo Review

The Dexcom Stelo represents a significant step forward in making continuous glucose monitoring accessible to people without diabetes. For those managing prediabetes, exploring metabolic health, or simply curious about how their bodies respond to food and activity, the Stelo offers a straightforward entry point into glucose tracking without the prescription requirements of traditional CGMs.

The device's 15-day wear time, discreet profile, and user-friendly app make it practical for everyday use. The real-time glucose readings and trend arrows help users identify patterns that might otherwise go unnoticed — the post-meal spike after a seemingly healthy breakfast, the overnight dip that explains morning fatigue, or the steady climb during a stressful workday. For many users, these insights translate into concrete changes: adjusting meal timing, rethinking snack choices, or recognizing how sleep and stress affect their numbers.

What the Stelo Does Well

The Stelo excels at accessibility. The over-the-counter availability removes a major barrier, and the setup process is genuinely simple — scan the sensor with your phone, wait for the two-hour warmup, and start tracking. The app presents glucose data in plain language, with educational prompts that help new users interpret what they're seeing without overwhelming them with clinical detail.

For users who've never worn a CGM, the Stelo's accuracy in the non-diabetic glucose range (70–180 mg/dL) is reassuring. While it's not designed for insulin dosing and shouldn't be used that way, it provides reliable trend data for understanding how daily choices affect glucose levels. The 15-day sensor life means fewer applications and less hassle compared to shorter-wear options.

Limitations to Consider

The Stelo isn't a medical diagnostic tool, and it's not intended for anyone taking insulin or managing diabetes with medication that carries hypoglycemia risk. Its glucose range is optimized for the patterns seen in prediabetes and metabolic exploration, not for the wider swings that can occur with insulin therapy. Users should confirm their eligibility before purchasing — the device is FDA-cleared for adults 18 and older who are not on insulin.

The subscription model, while competitively priced for the CGM category, is a recurring cost that adds up over time. Users should weigh whether the ongoing expense aligns with their health goals, especially if they're using the device for short-term experimentation rather than long-term monitoring. Additionally, the Stelo's data stays within the app; there's no direct integration with electronic health records or the ability to share readings with a care team in real time, which may matter for users working closely with a dietitian or endocrinologist.

Who Should Consider the Stelo

The Dexcom Stelo makes the most sense for adults with prediabetes who want to see how lifestyle changes affect their glucose in real time, individuals exploring metabolic health or preparing for a dietary shift, and people who've been told their fasting glucose or A1C is "borderline" and want more granular data before their next appointment. It's also a reasonable choice for anyone curious about glucose tracking who meets the eligibility criteria and is comfortable with the ongoing cost.

For a broader look at how the Stelo compares to other over-the-counter CGM options, see our guide to the best CGM for non diabetics, which covers eligibility, features, and pricing across the current OTC landscape.

Final Verdict

The Dexcom Stelo delivers on its core promise: accessible, understandable glucose monitoring for people who don't have diabetes but want to understand their metabolic patterns. It's not a replacement for medical advice or a diagnostic tool, but it's a practical resource for users ready to translate glucose data into everyday decisions. If you're in the target audience — managing prediabetes, exploring how food and activity affect your numbers, or working with a care team on metabolic health — the Stelo offers a clear window into patterns that might otherwise remain invisible.

For users on the fence between the Stelo and similar devices, the decision often comes down to sensor wear time, app preferences, and cost structure. The Stelo's 15-day wear and established Dexcom app ecosystem are strong points; other devices may offer shorter wear periods or different data presentations. The right choice depends on your specific goals and how you plan to use the information.

Glucose monitoring — whether with a CGM or through traditional fingersticks — is a tool, not a destination. The Stelo can help you spot trends and test hypotheses about your own metabolism, but the real work happens in how you respond to what you learn. Confirm your eligibility, set clear goals for what you want to discover, and use the data to inform conversations with your care team rather than as a standalone diagnostic. That's where the Stelo's value becomes real.